ANCA-Associated Vasculitis

被引:1
|
作者
Sharma, Purva [1 ]
Zonozi, Reza [2 ,3 ]
Geetha, Duvuru [4 ]
机构
[1] Northwell Hlth, Glomerular Ctr, Div Kidney Dis & Hypertens, Great Neck, NY USA
[2] Nephrol Associates Northern Virginia, Fairfax, VA USA
[3] Inova Fairfax Hosp, Falls Church, VA USA
[4] Johns Hopkins Univ, Sch Med, Div Nephrol, Baltimore, MD USA
来源
ADVANCES IN KIDNEY DISEASE AND HEALTH | 2024年 / 31卷 / 03期
关键词
ANCA; Rituximab; Plasmapheresis; Vasculitis; ANTIBODY-ASSOCIATED VASCULITIS; RHEUMATOLOGY CLASSIFICATION CRITERIA; 2022; AMERICAN-COLLEGE; ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES; DAILY ORAL CYCLOPHOSPHAMIDE; RANDOMIZED-TRIAL; PLASMA-EXCHANGE; RENAL SURVIVAL; CRESCENTIC GLOMERULONEPHRITIS; WEGENERS-GRANULOMATOSIS;
D O I
10.1053/j.akdh.2024.04.005
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
ANCA-associated vasculitis (AAV) is a necrotizing, small-to-medium vessel vasculitis associated with significant morbidity and mortality. AAV is a systemic autoimmune disease affecting kidneys, eyes, sinuses, peripheral nerves, skin, and upper and lower respiratory tracts. AAV tends to present in characteristic phenotypes categorized clinically as granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic GPA (EGPA). Kidney involvement is a common feature of AAV, and has important implications on disease prognosis and management. Existing therapies have been refined and improvements in our understanding of the pathophysiology of AAV has led to approval of novel therapies. In this review, we provide an overview of epidemiology, disease mechanisms, clinical presentation and review therapeutic strategies for induction and maintenance of remission.
引用
收藏
页码:194 / 205
页数:12
相关论文
共 50 条
  • [21] Updates in ANCA-associated vasculitis
    Pagnoux, Christian
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2016, 3 (03) : 122 - 133
  • [22] ANCA-associated Vasculitis Preface
    Fessler, Barri J.
    Bridges, S. Louis, Jr.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2010, 36 (03) : XIII - XIII
  • [23] RITUXIMAB IN ANCA-ASSOCIATED VASCULITIS
    Mukhtyar, Chetan
    RHEUMATOLOGY, 2013, 52 : 5 - 6
  • [24] ANCA-Associated Vasculitis With Hypocomplementemia
    Diaz Garcia, Juan D.
    Alamilla Sanchez, Mario
    Yanez Salguero, Valeria
    Yama Estrella, Martin B.
    Ortega, Jose L.
    Morales Lopez, Enrique F.
    Nieto, Julio C.
    Lopez, Claudia B.
    Ramirez, Irving G.
    Garcia Lascurain, Francisco Velasco
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 492 - 492
  • [25] Spectrum of ANCA-Associated Vasculitis
    Aditi Sinha
    Arvind Bagga
    The Indian Journal of Pediatrics, 2017, 84 : 737 - 738
  • [26] Refractory ANCA-associated vasculitis
    Gopaluni, Seerapani
    Egan, Allyson C.
    Xipell, Marc
    Jayne, David R. W.
    RHEUMATOLOGY, 2021, 60 : 63 - 66
  • [27] Classification of ANCA-Associated Vasculitis
    Khan, Irfan
    Watts, Richard A.
    CURRENT RHEUMATOLOGY REPORTS, 2013, 15 (12)
  • [28] ANCA-associated vasculitis of the appendix
    Leaver, Phillip J.
    Jang, Helena S.
    Wong, Muh G.
    Soh, Hwei-Choo
    Fernando, Suran L.
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2019, 3 (02)
  • [29] Immunopathology of ANCA-associated vasculitis
    Elena, C
    Antje, M
    Wolfgang, G
    INTERNAL MEDICINE, 1999, 38 (10) : 759 - 765
  • [30] Treatment of ANCA-associated vasculitis
    Schoenermarck, Ulf
    Gross, Wolfgang L.
    de Groot, Kirsten
    NATURE REVIEWS NEPHROLOGY, 2014, 10 (01) : 25 - 36